New drugs in early development for treating multiple myeloma: all that glitters is not gold
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2020.1772753
Abstract: ABSTRACT Introduction The last twenty years have introduced new therapeutic agents for multiple myeloma (MM); these include proteasome inhibitors (PIs), immunomodulatory drugs (IMDs) and monoclonal antibodies (mAbs). However, MM remains incurable, hence there is an… read more here.
Keywords: early development; drugs early; development treating; multiple myeloma ... See more keywords